Tablet Note: Doses differ according to formulation used and thus tablets and chewable tablets are not equivalent. When prescribing, the formulation must be specified
Non-nucleoside reverse transcriptase inhibitors
Non Formulary Items
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Green -Medicines suitable for routine use within primary care and Secondary care
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies
Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.
Red-Hospital initiation and continuation only
AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised
To be supplied from the appropriate commissioned provider.
GREEN 2- to be prescribed by primary care only
GREY- NON FORMULARY (As agreed by Area Prescribing Committee)